The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Tonix Pharmaceuticals Holding Corp shares valued at $86,200 were purchased by LEDERMAN SETH on May 15 ’25. At $21.55 per share, LEDERMAN SETH acquired 4,000 shares. The insider’s holdings grew to 4,005 shares worth approximately $0.15 million following the completion of this transaction.
As published in their initiating research note from Noble Capital Markets on April 18, 2022, Tonix Pharmaceuticals Holding Corp [TNXP] has been an Outperform. Analysts at ROTH Capital upgraded the stock from ‘”a Neutral”‘ to ‘”a Buy”‘ outlook in a report released in mid April. As of August 18, 2017, ROTH Capital has increased its “Neutral” rating to a “Buy” for TNXP. Earlier on September 07, 2016, ROTH Capital downgraded its rating. Their new recommendation was “a Neutral” for TNXP stock which previously was a “a Buy”.
Analyzing TNXP Stock Performance
On last trading session,, Tonix Pharmaceuticals Holding Corp [NASDAQ: TNXP] plunged -9.41% to $38.62. The stock’s lowest price that day was $38.46, but it reached a high of $43.7499 in the same session. During the last five days, there has been a drop of approximately -15.16%. Over the course of the year, Tonix Pharmaceuticals Holding Corp shares have dropped approximately -29.78%.
Support And Resistance Levels for Tonix Pharmaceuticals Holding Corp (TNXP)
RSI (Relative Strength Index) is 45.13 on the 14-day chart, showing neutral technical sentiment.
Is Tonix Pharmaceuticals Holding Corp subject to short interest?
Stocks of Tonix Pharmaceuticals Holding Corp saw a sharp rise in short interest on 2025-07-15 jumping by 58719.0 shares to 1.19 million. Data from Yahoo Finance shows that the short interest on 2025-06-13 was 1.13 million shares. A jump of 4.94% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 1.6 of the overall float, the days-to-cover ratio (short ratio) jumped to 1.6.
